CJ BIO Showcases Science-Backed Nutrition Solutions at SSG 2025
NDI-Completed Strength Solutions for Every Muscle's Need
The lineup includes WellNrich Leanepic™, a proprietary botanical extract designed to support muscle health naturally. It has successfully received FDA NDI Notification in July of 2025, demonstrating its safety and regulatory compliance in the U.S. market. Leanepic™ is a Plant-based Rosemary Concentrate, a proprietary extract refined by science and standardized to contain 50% ursolic acid for improved muscle health.
Also featured is BiomeNrich™ POST M005 (pasteurized Akkermansiamuciniphila), the first Akkermansia strain to complete FDA New Dietary Ingredient (NDI) notification, s supporting both healthy aging and aging well—helping proactive individuals maintain vitality, mobility, and muscle health through microbiome innovation.
Beauty Within, Powered by Biotics
BiomeNrich™ condition-specific biotic solutions support better sleep, radiant skin tone, enhanced skin immunity, and healthy weight management—demonstrating how inner microbial balance translates into visible beauty and overall well-being.
Holistic Health, Powered by Fermentation and Bifidobacterium
Solutions featuring Lactiplantibacillusplantarum from kimchi and Bifidobacterium strains support gut health and overall well-being, while AMINATURE® L-Arginine and L-Histidine contribute to personal care and vitality, offering a comprehensive approach to holistic wellness.
Join Us
At Booth #2865, visitors can explore
To schedule a meeting or learn more about
About CJ BIO Taste & Nutrition Business
View original content to download multimedia:https://www.prnewswire.com/news-releases/cj-bio-showcases-science-backed-nutrition-solutions-at-ssg-2025-302583233.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In HelloNation Routine Dental Checkup Explained Featuring Family Dental Expert Dr. Lalitha Kothuri, DDS
- Allspring Closed-End Funds Declare Monthly and Quarterly Distributions
- BARRANCO ANNOUNCES CLOSING OF DEBT SETTLEMENT
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share